Although this tenet had already been implied in 1979 by Rothwell and Stock (21), direct experimental evidence for a significant role for UCP1 in counteracting obesity has been limited to the metabolic consequences of ablation of UCP1. This evidence concerns the gene UCP1 and obesity due to melanocortin 4 receptor deficiency.